Recurrent Miller Fisher syndrome: clinical and laboratory features and HLA antigens

J Neurol Sci. 1999 Jun 1;165(2):139-43. doi: 10.1016/s0022-510x(99)00095-7.


In rare cases, Miller Fisher syndrome (MFS) has been known to recur. However, clinical features of recurrent MFS have not been well analyzed, and the precipitating factors relating to recurrence remain unknown. From 1981 to 1996, we examined four patients with recurrent MFS among 28 Japanese MFS patients. In the four patients, the recurrent episodes occurred after long asymptomatic intervals, ranging from 2.5 to 12.5 years. The clinical and laboratory features of recurrent episodes were similar either to those of the initial episodes or to those of the 24 non-recurrent patients. Of the two patients tested for serum IgG anti-GQ1b antibody, both were positive. Serological HLA typing showed that all recurrent patients were both HLA-Cw3 and -DR2 positive. However, out of 13 non-recurrent patients examined, six had HLA-Cw3, and four had HLA-DR2. The frequency of HLA-DR2 among the recurrent patients was significantly higher than among healthy controls (corrected P = 0.038), and was also higher than among the non-recurrent patients but not significantly. These findings suggest that recurrent MFS is clinically the same as typical MFS and that HLA-DR2 is possibly associated with recurrence.

Publication types

  • Case Reports
  • Clinical Trial
  • Comparative Study

MeSH terms

  • Adult
  • Ataxia / etiology
  • Female
  • HLA Antigens / cerebrospinal fluid
  • HLA Antigens / metabolism*
  • Histocompatibility Testing
  • Humans
  • Male
  • Middle Aged
  • Miller Fisher Syndrome / cerebrospinal fluid
  • Miller Fisher Syndrome / immunology*
  • Miller Fisher Syndrome / physiopathology*
  • Neurologic Examination
  • Ophthalmoplegia / etiology
  • Recurrence
  • Reflex, Abnormal / physiology


  • HLA Antigens